Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody engineered to specifically target and bind to tumor necrosis factor-alpha (TNF-??). By binding to TNF-??, Infliximab inhibits its interaction with its receptors, TNFR1 and TNFR2, effectively modulating the inflammatory response. This antibody is widely utilized in the study of autoimmune and chronic inflammatory diseases, as well as in research focused on diabetic neuropathy. Infliximab serves as a critical tool in elucidating the pathophysiological mechanisms underlying these conditions and in the development of therapeutic strategies.
Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody engineered to specifically target and bind to tumor necrosis factor-alpha (TNF-??). By binding to TNF-??, Infliximab inhibits its interaction with its receptors, TNFR1 and TNFR2, effectively modulating the inflammatory response. This antibody is widely utilized in the study of autoimmune and chronic inflammatory diseases, as well as in research focused on diabetic neuropathy. Infliximab serves as a critical tool in elucidating the pathophysiological mechanisms underlying these conditions and in the development of therapeutic strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
